Loading clinical trials...
Loading clinical trials...
Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy for Prostate Cancer (Mirage): A Phase III Randomized Trial
Conditions
Interventions
CT-guided Stereotactic Body Radiation Therapy
MRI-guided Stereotactic Body Radiation Therapy
+1 more
Locations
1
United States
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Start Date
May 12, 2020
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2027
Last Updated
December 22, 2025
NCT05691465
NCT06205316
NCT06470750
NCT04134260
NCT05053152
NCT05050084
Lead Sponsor
Jonsson Comprehensive Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions